Rethinking Off-Label Regulation in the Wake of Sorrell v. IMS Health: Can State Involvement Compensate for Waning FDA Authority to Curb Commercial Free Speech?

Zborowsky, Ashley A.2013-08-272013-08-272012Minnesota Journal of Law, Science & Technology, Volume 13, Issue 2 (Spring 2012), pages 925-9491552-9541https://hdl.handle.net/11299/155954enRethinking Off-Label Regulation in the Wake of Sorrell v. IMS Health: Can State Involvement Compensate for Waning FDA Authority to Curb Commercial Free Speech?Article